Cell sheet therapy has emerged as a potential therapeutic option for reparation and reconstruction of damaged tissues and organs. However, an effective means to assess the fate and distribution of transplanted cell sheets in a serial and noninvasive manner is still lacking. To investigate the feasibility of tracking Adipose derived stem cells (ADSCs) sheet in vivo using ultrasmall super-paramagnetic Fe 3 O 4 nanoparticles (USPIO), canine ADSCs were cultured and incubated with USPIO and 0.75 μg/ml Poly-LLysine (PLL) for 12 h. Labeling efficiency, cell viability, apoptotic cell rate were assessed to screen the optimum concentrations of USPIO for best labeling ADSCs. The results showed ADSCs were labeled by USPIO at an iron dose of 50 μg/ml for a 12 h incubation time, which can most efficiently mark cells and did not impair the cell survival, self-renewal, and proliferation capacity. USPIO-labeled ADSCs sheets can be easily and clearly detected in vivo and have persisted for at least 12 weeks. Our experiment confirmed USPIO was feasible for in vivo labeling of the ADSCs sheets with the optimal concentration of 50 μg Fe/ml and the tracing time is no less than 12 weeks.
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To track cell sheet survival and migration in vivo, it is important to be able to provide serial images from weeks to months after transplantation. Magnetic Resonance Imaging (MRI) offers an established and high-resolution approach to dynamically and persistently detect a small fraction of labeled cells in vitro and vivo. Thus it can be used as an ideal tracer method. At present, there are two main groups of paramagnetic contrast agents used for MRI, gadolinium (Gd) based chelates and iron oxide (Fe) based particles. Gadolinium rhodamine dextran (GRID) is the most commonly used MR contrast agents in clinical practice. However, GRID significantly increases the level of reactive oxygen species (ROS) and affects cell proliferation 10 . Iron is a basic element in cellular metabolism, and involved in a series of crucial physiological events, such as oxygen transport, mitochondrial respiration, and DNA synthesis 11 . Many studies have shown labeling with optimized superparamagnetic iron oxide nanoparticles (SPIO) does not trigger cell apoptosis, and does not impair cell survival or proliferation capacity [12] [13] [14] [15] . SPIOs are divided into three main categories according to different hydrodynamic diameters, including oral SPIO, standard SPIO, and ultrasmall SPIO (USPIO). For USPIO, the hydrodynamic diameter size of nanoparticle is less than 50 nm 16 . MR signal enhancement is closely associated with particle size, and the smaller iron oxide provided greater signal enhancement and prolonged signal enhancement 17 . From early reports, USPIO has been evaluated as an MR contrast agent for imaging cells and scaffolds in vitro and in vivo 12, [18] [19] [20] . Nevertheless, there has been no report on USPIO-labeled cell sheets and their use to further obtain non-invasive imaging information on transplanted USPIO-labeled cell sheet in vivo. In this study, we chose ADSCs as seed cells and describe a simple protocol to label ADSCs sheets using USPIO at optimized concentration and demonstrate the feasibility of noninvasive imaging of labeled ADSCs sheet after transplantation in vivo.
Experimental Procedures
Materials. Ferric citrate, ferrous (II) sulfate heptahydrate (FeSO 4 .7H 2 O, 99%) and NaOH were purchased from by Sinopharm Chemical Reagent Co., Ltd. (Shanghai, China). Ascorbic acid (AA) was obtained from Aladdin Chemical Reagent Co., Ltd. (Shanghai, China). The Cell Counting Kit-8 assay (CCK-8) was purchased from Dojindo Laboratories (Japan). Cell culture products and reagents were purchased from Thermo Scientific (Rockford, IL, USA). Beagle dogs, at the start of the study 10 months of age, and nude mice of 4 weeks of age were provided by the Shanghai sixth people's hospital Animal Laboratory. The experimental protocol was reviewed and approved by the Ethics Committee and is in compliance with the guidelines for the ethical treatment of animals made by the International Council for Laboratory Animal Science. The water used in all experiments was ultrapure water, which was purified by a Milli-Q Water System (18.2 MΩ cm, Millipore Co., USA). The life sciences committees of Shanghai Jiao Tong University approved the experiments, and all experimental procedures were in agreement with institutional use and care regulations.
Synthesis and characterization of USPIO.
Continuing from our previous studies 21 , 22 , herein we developed a hydrothermal method for controllable synthesis of USPIO nanoparticles. The USPIO nanoparticles were prepared by a hydrothermal method using FeSO 4 ·7H 2 O, ferric citrate and ascorbic acid as raw materials. In brief, 10 mL FeSO 4 ·7H 2 O solution was added to a 30 mL ferric citrate solution in a molar ratio of 2:1 under strong stirring at room temperature. 0.6 mmol ascorbic acid as antioxidant was dissolved in the mixture, and then the pH of the solution was brought to 10 using a 1.5 M NaOH solution. Subsequently, the obtained precursors were poured into a 50 mL Teflon-lined autoclave, which was kept at 200 °C for 10 h and then returned to ambient temperature. The resulting solution was dialyzed by MWCO 14 kDa of dialysis bag for 24 h. To remove bacteria, the above Fe 3 O 4 nanoparticle solution was then filtered through a 0.22 μ m nylon filter. The crystallinity of the synthesized USPIO was determined with an X-ray powder diffractometer (XRD, Rigaku, Japan) using Cu Kα radiation at 1.5418 Å at a scanning rate of 5° min −1 . Zeta potential measrements were carried out using a NICOMP 380 ZLS ζ potential/particle sizer (PSS Nicomp, USA). Transmission electron microscopy (FEI Tecnai G2 Spirit Twin, Czech Republic) was used to observe the crystal structure and sizes.
Cell cultures. As a common large experimental animal, canines were used in our study for abundant subcutaneous fat, their similarity to human physiology and strong disease resistance. The primary culture of Canine ADSCs were prepared as reported previously 23 . Briefly, ADSCs were isolated by an enzymatic digestion method. After general anesthesia, primary ADSCs were obtained from fat tissue in the groin of beagle dogs, then digested with 0.1% collagenase I for 1 h at 37 °C. The digested cells were collected after filtration through a cell strainer. The primary ADSCs were maintained in low glucose Dulbecco modified Eagles (DMEM, Gibco, NY, USA) supplemented with 10% fetal bovine serum (FBS, Gibco, NY, USA), 100 U/mL penicillin (Gibco, NY, USA), 100 mg/mL streptomycin sulfate (Gibco, NY, USA). The culture medium was replaced every 2-3 days.
Cell sheets preparation and labeling. Canine ADSCs at passages 2 were grown in 12-well plate until cell growth reached 80-90% confluence. The polyamine poly-L-lysine (PLL) hydrobromide (Sigma, St Louis, Mo, 175,000 MW) was used as the transfection agent. Canine ADSCs were incubated with USPIO and 0.75 μ g/ml PLL. These culture media containing the USPIO-PLL complex were added to the ADSCs such that the final concentration of Fe in USPIO was 5 μ g/mL, 10 μ g/mL, 25 μ g/mL, 50 μ g/mL, 100 μ g/mL, respectively. Meanwhile, unlabeled ADSCs were used as control. The cell cultures were incubated for 12 h at 37 °C in 5% CO 2 atmosphere. After incubation for 12 h, cells were washed three times with phosphate-buffered saline (PBS) and further cultured in low glucose DMEM supplemented with 10% FBS. For cell sheet labeling, ADSCs at 5 × 10 4 per cm 2 were seeded in a 60 mm Temperature-Responsive Cell Culture Surface (Thermo Fisher Scientific, San Jose, CA, USA) until the cell growth reached 90%-100% confluence (2-3 days). Then, the optimum concentration of USPIO was used to label the ADSCs. Vitamin C catalyzes the hydroxylation of prolyl and lysyl residues in the collagen polypeptide chains, allowing interaction of the collagen subunits, adding structural stability to the collagen fibers, thus it plays a vital role in the production of collagen 24 . In this study, the secretion of extracellular matrix were stimulated with 100 μ g/mL vitamin C (Sigma, St.Louis, USA) for 3 days, and then 50 μ g/mL vitamin C (Sigma, St Louis, USA) for 18 days to form the cell sheet. The culture medium was replaced every 2 days.
Prussian blue staining and Iron Quantificationh. After Cellular cytotoxicity assessment. CCK-8 is a sensitive non-radioactive colorimetric assay for detecting the number of viable cells in cytotoxicity and cell proliferation assays 25 . The sensitivity of cell proliferation assays using CCK-8 is higher than other tetrazolium salts, such as XTT, MTT, WST-1 or MTS 25 . According to the manufacturer's instructions, cellular cytotoxicity of different concentrations of USPIO-labeled ADSCs was determined with a cell counting Kit-8 (Dojindo, Tokyo, Japan). 100 μ L ADSCs suspensions (2 × 10 3 /well) were added to 96-well plates. The cells were cultured to 80-90% confluence, different concentrations of USPIO and 0.75 μ g/ml PLL was added to each well for 12 hours incubation. After washing three times with PBS, ADSCs were continuously cultured in 100 μ L low glucose DMEM supplemented with 10% FBS. 10 μ L of CCK-8 was added in 96 wells every 24 hours. After 2 h incubation, optical density (OD) values at 450 nm were measured with a standard microplate reader (TECAN, Männedorf, Switzerland). This experiment was continued for 7 days, then growth curves were created to compare varying concentrations of USPIO-labeled and unlabeled cells. 
Transmission electron microscope. Transmission electron microscopy (FEI Tecnai G2 Spirit Twin, Czech
Republic, operating at 80 kV) was used to analyse the intracellular distribution of USPIO in USPIO-labeled cells. First, the optimal concentration of USPIO that give the high transfection efficiency without any effects on cell growth was screened via the above steps. Then, the optimal concentration of USPIO-labeled and unlabeled ADSCs was fixed in 2.5% glutaraldehyde for 4 h, post-fixed in 1% osmium tetroxide in the same buffering solution for 2-3 h, contrasted in block with 0.5% uranyl acetate for 2 h, dehydrated using graded ethanol/acetone and included in Araldite ® resin. The ultra-thin cuts (50-60 nm) were contrasted in alcoholic solution saturated with uranyl acetate and lead citrate for 20 minutes, then observed and analyzed in FEI Tecnai G2 Spirit Twin.
Multipotent differentiation of USPIO-labeled ADSCs.
To observe the differentiation potential of USPIO-labeled ADSCs, osteoblast, myoblast and adipocyte differentiation assays were performed in vitro. The unlabeled ADSCs were used as a control group. Osteogenic differentiation of ADSCs was cultured under the osteogenic induction medium for 3 weeks, containing 90% low glucose DMEM supplemented with 10% FBS, dexamethasone, 50 μ g/ml ascorbic acid and b-glycerol phosphate. For adipogenic differentiation, ADSCs were incubated in adipogenic medium for 3 weeks, which consists of 90% DMEM supplemented with 10% FBS, insulin, indomethacin, 1-methyl-3-isobutylxanthine, and dexamethasone. Osteogenic and adipogenic differentiation were detected by alizarin red staining and oil red staining in accordance with manufacturer's instructions, respectively. In a previous study, our group isolated ADSCs and induced them into myoblast with 5-Azacytidine in vitro, and successfully treated stress urinary incontinence of rat 26 . Similarly, we also induced the myogenic differentiation of USPIO-labeled and unlabeled ADSCs by 5-Azacytidine for 3 weeks. The muscle protein expression of Desmin (1:300 antibody dilution, SantaCruz Inc, Santa Cruz, CA) was detected by indirect immunofluorescence staining and observed under the fluorescence microscope.
Transplantation of USPIO-labeled ADSC sheet. For easy operation and elimination of immune rejection, immune-deficient nude mice were used as experimental animal for in vivo transplantation further assessed the fate of the USPIO-labeled cells in the transplanted areas by MRI. After 12 h incubation at the optimal concentration of USPIO-containing medium, ADSCs were washed three times with PBS, and then continuously cultured for 21 days and formed cell sheets with the stimulation of vitamin C. The culture medium was replaced every 2 days. As a flexible and thin sheet tissue composed of cells and ECM, the cell sheet is hard to transplant smoothly under the skin. After cell sheet formation, USPIO-labeled and unlabeled ADSC sheets were folded and stacked to cell sheet "pellets" with cell scraper, which made it easier to transport the sheets and fix them in vivo. Before transplantation of the cell sheet "pellets", nude mice (4 weeks) were anesthetized with pentobarbital-sodium (25-30 mg/kg ip). A 1.5 cm incision was made in the dorsal skin, and underlying space between skin and muscle was exposed. Then, three cell sheet "pellets" from each group were transplanted onto the under skin space and the incision was closed with 5-0 nylon sutures. Magnetic resonance imaging in vitro. Varying concentrations of USPIO (5 μ g Fe/mL, 10 μ g Fe/mL, 25 μ g Fe/mL, 50 μ g Fe/mL, 100 μ g Fe/mL) labeled and unlabeled cells were washed twice with PBS, trypsinized, fixed through incubation with 4% paraformaldehyde for 15 minutes and cells collected at 500× g centrifugation for 3 min. Then, 2 × 10 5 cells were resuspended with 1 mL PBS in 1.5 mL tubes. MR imaging (3.0 T; PharmaScan, Bruker, Germany) was used to determine the sensitivity of MRI for the detection of varying concentrations of USPIO-labeled cells using multi-slice T2-weighted spin echo sequences. Imaging parameters for T2-weighted turbo spin-echo (SET2WI) were as follows: repetition time (TR) = 470.1 ms, echo time (TE) = 7.5 ms, field of view (FOV) = 2.5 × 2.5 cm 2 , matrix = 384 × 384, slice thickness = 0.2 mm, spacing layer = 0.45 mm, and flip angle = 15°. An equal amount of PBS in 1.5 mL tubes was used as control.
Magnetic resonance imaging in vivo.
To further observe the magnetic resonance images of transplanted USPIO-labeled ADSCs sheet, 50 μ g Fe/mL USPIO-labeled and unlabeled ADSCs sheet "pellets" were examined by MRI 1 week, 4 weeks and 12 weeks after transplanting the cell sheets. To perform the MRI, animals were anesthetized with pentobarbital-sodium (25-30 mg/kg ip). After a gradient-echo localizer in three spatial directions, the T2-weighted MR images were acquired using Rapid Acquisition with Relaxation Enhancement sequence, specific parameter as follows: TE = 71 ms, TR = 3500 ms, RARE factor = 8, number of averages = 8, slice thickness = 1 mm, FoV = 70 × 100 mm, matrix = 384 × 384.
Histopathology. In week 1, 4, 12 after labeling and embedding into nude mice, nude mice were sacrificed and transplanted USPIO-labeled and unlabeled ADSC sheet "pellets" were removed and further fixed by 4% paraformaldehyde for 24 h, followed by paraffin embedding and sectioning (5 μ m in thickness). The sections were HE-stained for microscopic examination. Meanwhile, the presence of iron oxide in the transplanted area was detected by Prussian blue staining. The specific procedures of Prussian blue staining are described in the Prussian blue staining and Iron Quantification section. Finally, the differentiation of ADSC sheets in vivo was investigated 12 weeks after transplantation. Alizarin red staining (paraffin section), oil red staining (frozen section) and immunohistochemical staining (Desmin, 1:300 antibody dilution, paraffin section) were used to analyze the osteogenic, adipogenic and myogenic differentiation, respectively.
Statistical analysis. All data are expressed as means ± SD. To identify significant differences in the labeling efficiency, cellular apoptosis rate and grey value of MR imaging, one-way analysis of variance and unpaired student t test was applied. Cellular cytotoxicity of varying concentration of USPIO-labeled and unlabeled groups were analyzed with repeated measurement analysis of variance. P values less than 0.05 were identified to be statistically significant differences.
Results and Discussion
Flow cytometry analysis indicated, the primary cultured ADSCs in our study were negative for hematopoietic markers CD34 and CD45, and were strongly positive for MSC-related markers CD44, CD90 and CD105, which confirmed the stem cell origin of ADSCs (Supplementary Data 1) . Transmission electron microscopy (TEM) images were used to observe the crystal structure and sizes. TEM images showed the monodisperse USPIO nanoparticles were approximately spherical with an average diameter of 10 ± 2 nm (Fig. 1A) . High-resolution transmission electron microscopy (HRTEM) of a representative USPIO was observed in Fig. 1B . The lattice distance was measured to be 0.486 nm, consistent with the standard cubic Fe 3 O 4 structure 27 . The USPIO were further characterized by the X-ray diffraction (XRD) (Fig. 1C) . The XRD diffraction peaks of the as-synthesized USPIO were also shown to be due to the cubic Fe 3 O 4 structure (JCPDS no.19-0629). The excellent saturation moment of the USPIO nanoparticles was ~71 emu g −1 , indicating that the synthesized USPIO are superparamagnetic, which facilitate the magnetic resonance imaging of medical diagnosis. The hydrodynamic size of nanoparticles in water was approximately 10.5 ± 5.169 nm (PDI = 0.122), which was slightly bigger than the size in TEM. It may be attributed to the hydration of the ligand on the surface of USPIO in ultrapure water, in accordance with the published literature 28 . USPIO nanoparticles have attracted considerable interest due to their biocompatibility, biodegradability and excellent magnetic properties 29 . An ideal tracer agent requires high detection sensitivity while not having an influence on the activity of cells. There is considerable differences in the doses of USPIO reported in literature. Chen et al. 14 showed labeling endothelial are progenitor cells with USPIO at a concentration of 28 μ g Fe/mL for 24 h was nearly 100% efficient and did not affect cell viability. Paik et al. 30 showed that iron nanoparticles used at a concentration of 1% were non-toxic to the bone marrow cells and both the secretion of cytokines and expression of cell surface markers will not be affected. Oude-Engberink et al. 18 confirmed that incubating human monocytes with USPIOs (1000 μ g Fe/mL) results in efficient labeling detectable on MR images and does not affect cellular activity and activation markers such as cytokine production and cell migration. Furthermore, it has been proven that iron nanoparticles induce a significant increase in the production of ROS and subsequent microtubule remodeling 31 . Overproduction of ROS have been shown to be associated with various pathologic changes, such as cell structural damage, carcinogenesis, inflammation, radiation and reperfusion injury 32 . The uptake of iron oxide particles by cells is highly dependent on the cell types, cell size, surface charge, and coating of the particles. There is no single standard dosage that is appropriate for all cell types, thus we firstly explore the optimum concentration of USPIO for canine ADSCs labeling. As a cationic polymer, PLL can effectively boost the intracellular uptake of the nanoparticles through electrostatic interactions 15 . Compared with iron oxide alone, the iron nanoparticles and PLL mixture is more effective in achieving desired relaxation time 12 . Various concentrations of PLL have been used in the literature reports, from 0.375 μ g/mL to 1.5 μ g/mL 12, 33, 34 . Excessive PLL can form toxic aggregates and inhibit the nano-sized iron oxide incorporation in the cells, thus we chose a moderate concentration of PLL of 0.75 μ g/mL. In this study, the zeta potential of 0.75 μ g/mL PLL was detected as 5.33 mV, and it gradually dropped Scientific RepoRts | 7:42793 | DOI: 10.1038/srep42793 from 4.81 mV to 2.79 mV with mixing the increasing concentrations of USPIO from 5 μ g Fe/mL to 100 μ g Fe/ mL. The positive lysine charges of the PLL/USPIO complexes balance the negative phosphate charges on the cell membrane, and further enhance the cell endocytosis 35 , which could contribute to the iron nanoparticles uptake and obviously reduce the dosage of USPIO.
The iron content per cell increased with increasing incubation time, and reached saturation at 12 h of incubation (Supplemental Data 2). After incubation for 12 h with varying concentrations of USPIO nanoparticles, the labeling efficiency was detected by Prussian blue staining, as shown in Fig. 2A . The USPIO-labeled ADSCs exhibited an increasingly strong blue staining with the increasing concentrations of USPIO from 5-100 μ g Fe/mL. Intracellular blue spots represent spread USPIO nanoparticles and mostly concentrated in the perinuclear region of the cytoplasm. ICP-MS in Fig. 2B showed the average iron content was 0.17 ± 0.036 pg/cell for 0 μ g Fe/mL, 5.29 ± 1.225 pg/cell for 5 μ g Fe/mL, 6.63 ± 1.117 pg/cell for 10 μ g Fe/mL, 17.07 ± 2.325 pg/cell for 25 μ g Fe/mL, 28.48 ± 3.806 pg/cell for 50 μ g Fe/mL,42.42 ± 6.843 pg/cell for 100 μ g Fe/mL. This indicated the iron content per cell is proportional to the iron concentrations in a range of 5-100 μ g/mL (P < 0.05).
CCK-8 assay was used to detect the proliferation of USPIO-labeled cells and assess the cellular cytotoxicity of USPIO. The growth curves labeled cells with varying concentration of USPIO and unlabeled cells ware shown in Fig. 3 . The data indicate, compared with unlabeled cells, no cellular cytotoxicity due to USPIO was found in the iron concentration range of 5-50 μ g/ml and cells incubated with PLL alone, p > 0.05. The OD value of 100 μ g Fe/mL labeled cells was significantly lower than unlabeled cells (p < 0.05). These results suggested that USPIO was not cytotoxic with good biocompatibility to ADSCs with a final iron concentration of less than 50 μ g/ml.
Furthermore, annexin V-FITC/PI double staining was performed to analyze the proportion of apoptotic cells in the varying concentration of USPIO-labeled and unlabeled cells. The results are shown in Fig. 4 . The proportion of apoptotic cells in the USPIO-labeled cell samples was (2.9 ± 0.50)% for 5 μ g/ml, (2.9 ± 0.32)% for 10 μ g/ml, (3.1 ± 0.36)% for 25 μ g/ml, (3.4 ± 0.25)% for 50 μ g/ml, (8.8 ± 1.75)% for 100 μ g/ml, whereas the proportion of apoptotic cells in the unlabeled cell (0 μ g/ml) samples was (2.7 ± 0.42)% and cells incubated with PLL alone was (2.7 ± 0.46)%. Although the populations of apoptotic cells increased with concentration of USPIO, no significant difference was observed between the unlabeled and labeled cells at an iron concentration of 5-50 μ g/ml, p > 0.05. Furthermore, the difference between unlabeled cells and cells incubated with PLL alone was not found to be statistically significant, p = 0.892. Compared with unlabeled cells, a statistically significant increase of apoptosis rate was apparent at 100 μ g Fe/ml concentrations, p < 0.01. Thus, according to the labeling efficiency, cellular cytotoxicity and cellular apoptosis rate assessment, we chose to use USPIO at a Fe concentration of 50 μ g/ml for a 12 h incubation, which can most efficiently mark cells and did not impair the cell survival, self-renewal, and proliferation capacity, and this concentration was screened to use for further experiments. After 12 h incubation with an iron concentration of 50 μ g Fe/ml, the uptake of USPIO particles into the cells was investigated using transmission electron microscopy. In Fig. 5A -D, similar to unlabeled ADSCs, the cellular structure and morphology of USPIO-labeled ADSCs were integral and clear, and the cell membrane did not appear to be damaged. USPIO was taken into cell through a membrane adsorption process and subsequent intracellular (non-nuclear) localization is found in endosomes 20 . Dark black spots indicate USPIO particles. A fraction of USPIO particles were found to be adhered to the cell plasma membrane and with no distribution in the nucleus, while most of them were incorporated into intracellular and aggregated in large lysosomes.
Several studies have suggested labeling stem cells with iron oxide in an appropriate concentration does not adversely affect the cell differentiation ability, including chondrogenic differentiation 36 , myogenic differentiation 37 , adipogenic differentiation 38 and neural differentiation 39 . However, the biological effects of iron nanoparticles on osteogenic differentiation of stem cells remain controversial. Xiao et al. 40 demonstrated that superparamagnetic iron oxide could promote osteogenic differentiation of rat ADSCs, while Fan et al. 41 showed the osteogenic and adipogenic potential of ADSCs were inhibited after SPIO labeling. One possible reason is that SPIOs can influence cell mobilization, involve the activation of relevant signaling pathway and further affect osteogenic differentiation ability 42 . High iron nanoparticle loads could have negative effects on cell viability and differentiation, thus it is important to choose the appropriate concentration. In our study, the USPIO-labeled ADSCs maintained a good differentiation potential and no significant difference was observed in the myogenic (Fig. 6A vs Fig. 6D), osteogenic (Fig. 6B vs Fig. 6E ) and adipogenic (Fig. 6C vs Fig. 6F ) differentiation ability in vitro between the USPIO-labeled and unlabeled groups (Fig. 6) .
To test the detectability in MRI, 2 × 10 5 varying concentrations of USPIO-labeled and unlabeled ADSCs were placed in 1.5 mL tube (Fig. 7A) and were detected as strongly hypointense areas on T2-weighted images (Fig. 7B) . A good correlation between the image grey-scale value and the concentrations of USPIO in the MR images was observed. Lighter gray represents lower iron concentrations and darker gray represents higher iron concentrations. There are significant differences in the gray value among varying concentrations of USPIO. Moreover, the Compared with unlabeled cells, there was no cellular cytotoxicity of USPIO in the iron concentration range of 5-50 μ g/ml and cells incubated with PLL alone, p > 0.05, while cell proliferation was inhibited at the iron concentration of 100 μ g/ml, p < 0.05. gray difference can be easily identified by the naked eye at concentrations greater than or equal to 25 μ g Fe/ml. These results indicated that MRI can efficiently detect USPIO-labeled ADSCs and that the intensity of the signal is proportional to the concentrations of USPIO.
Vitamin C was added to culture medium to accelerate native ECM secretion and generate a three dimensional tissue-like and contiguous cell sheets 43 . Various types of ECM and membrane proteins penetrate into the cell sheets and play a role as adhesive agents to limit cell distribution and migration. Thus cell sheets are intact whole before and after transplantation. Furthermore, MR imaging is applicable to continuously track the migration and location of transplanted cells, even for a small number of labeled cells (5 × 10 3 to 1 × 10 4 ) 44 or single cell images 45 . For cell sheets, the cell number is very large. The number of initial seeding cells is 1.05 × 10 6 cells per sheet in our experiments. The characteristics of large quantities of cells are favorable for detection of USPIO-labeled cell sheet by MRI imaging. For USPIO, the effect of MR contrast agents is not observed directly on the image, but the change of the relaxation rate of water protons is detectable by MRI 46 . Thus, iron oxide nanoparticles are seen as hypointensity or negative contrast on T2-weighted and T2*-weighted images and often referred to as "negative" contrast agents. In vitro MR imaging showed, compared with unlabeled cells or PBS, a visible hypointense signal can be provided at the concentrations of 25 μ g Fe/mL.
For in vivo MR imaging, the USPIO-labeled cell sheet "pellets" implants were visible as a hypointense area at the transplantation site and three-dimensional images could be further provided. Several studies have suggested the use of iron oxide nanoparticles via cell labeling as an effective MR contrast for detecting grafted cells and tissue over long times in animal experiments. Bulte et al. 20 showed SPIO-labeled oligodendroglial progenitors can be readily detected in vivo for 6 weeks after transplantation. Neri et al. 44 proved that low numbers of viable SPIO-labeled human neural precursor cells (5 × 10 3 to 1 × 10 4 ) could be efficiently detected in the adult murine brain after transplantation, and it could be tracked for at least 1 month in vivo. Furthermore, Guzman et al. 47 detected the targeted migration and distribution of SPIO-labeled clusters of cells up to 18 weeks. For monitoring of cell sheet transplantation, we further localize USPIO-labeled cell sheet by MRI after transplantation in the subcutaneous area of nude mice for at least 12 weeks. At 1 week, 4 weeks and 12 weeks after transplantation into the subcutaneous area of nude mice, we explored whether USPIO-labeled ADSCs sheet "pellets" could be localized by MRI, as shown in Fig. 7C . One week after implantation, regions of hypointense signal in T2 images were found in the transplantation sites of 50 μ g Fe/ml USPIO-labeled ADSCs sheet "pellets" and no MRI signals were detected when similar volume unlabeled ADSCs sheet "pellets" were transplanted. The signal was visualized up to 4 weeks and even 12 weeks after transplantation. Thus, our result showed USPIO-labeled ADSCs sheets can be easily and clearly detected in vivo and has persisted for at least 12 weeks. However, compared with 1 week after implantation, grey-scale value and area of hypointense signal nearly remain the same at 4 weeks after implantation and deceased at 12 weeks.
Histological analysis in Fig. 8A revealed that USPIO particles were a granular brown substance which was located mainly in the cytoplasm and there was no difference in cell morphology between labeled and unlabeled cells in the HE stained section. Prussian Blue staining revealed positive stained granules exclusively in the transplants of USPIO-labeled cells and presented an even distribution within the cell sheet. However, the blue-stained iron particles in the cytoplasm decrease gradually from week 1 to week 12 when these were transplanted into subcutaneous area (Fig. 8B) . Signal intensity was well correlated with iron accumulation. In our study, over 12 weeks the signal intensity of USPIO-labeled cell sheet reduced gradually with time, which was also proven by Prussian Blue staining. We analyzed the possible cause of the changes of signal intensity, including: 1) A fraction of the USPIO-labeled cells gradually migrating out of the cell sheet.
2) The iron particles in the magnetic labeled cells can be passed to offspring cells, and the concentration of iron particles can be diluted and decrease during cell division. 3) Iron oxide loading has been shown proved to increase activity of lysosomal cathepsin D, and the latter induces the cellular iron to gradually degrade in lysosomes 48 . Although most of the iron particles remains intact in the endosome 49 , some amount of the nano-sized iron oxide can be released from the labeled cell by exocytosis with time.
In addition, the osteogenic, adipogenic and myogenic differentiation were measured to evaluate the cell differentiation in vivo (Fig. 8C) . The result showed, apart from brown iron particle deposited within USPIO-labeled cell sheets, no spontaneous cell differentiation towards bone, fat and muscle was observed in both USPIO-labeled and unlabeled ADSCs sheets. Our study certified the feasibility of tracking ADSCs sheet with USPIO in vivo for a long time (12 weeks), however, due to the xenoplastic transplantation of ADSCs sheet, it is hard to detect the cell migration in this study, and further studies may focus on the cell sheet migration towards deep anatomical sites in homoplastic transplantation.
Conclusion
In summary, the ADSCs sheet can be effectively labeled with 50 μ g Fe/ml USPIO and 0.75 μ g/mL PLL. The particles did not impair cell survival, self-renewal, and proliferation capacity. USPIO might be feasible for in vivo labeling of the ADSCs sheets using the optimal concentration of 50 μ g Fe/ml. This level of concentration did not influence the cells' activity nor the cell apoptosis rate. MRI scanning on T2WI sequences can effectively track 5 ADSCs were treated with USPIO at the iron concentrations of 0-100 μ g/ml and PBS was taken as control, the signal intensity is proportional to the concentrations of USPIO, the gray difference can be easily identified by naked eye at the iron concentration of greater than or equal to 25 μ g/ml. (C): MRIs were examined at 1 week, 4 weeks, and 12 weeks after USPIO-labeled ADSCs sheet transplantation, white arrows represent the area of the USPIO-labeled and unlabeled ADSCs sheet, scale bar: 1 cm.
the USPIO nanoparticles labeled ADSCs in vivo for at least 12 weeks. MRI can be used to continuously track the ADSCs sheet labeled with USPIO transplanted into nude mice and provide a non-invasive method to understand the fate of the labeled cells in the transplanted areas. 
